Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol for postoperative cognitive function in elderly patients after laparoscopic gastrointestinal surgery
ChiCTR2000041189Phase 4Recruiting
- Sponsor
- Renmin Hospital of Wuhan University
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and propofol in gastrointestinal conditions (2 arms), sponsored by Renmin Hospital of Wuhan University. Primary endpoint: Incidence of perioperative neurocognitive disorders. Started Jan 2021; status: recruiting.
02
Drugs
remimazolampropofol
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on ChiCTR2000041189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041189.